Experts have ended part of a study which aimed to lessen diabetics' heart disease risk after they found it increased death risks, a report said.
The national study intended to lessen heart disease by reducing blood sugar to regular levels, Raleigh (N.C.) News & Observer reported Wednesday.
One study leader at the Diabetes Care Center at the University of North Carolina Hospitals said they are immediately ending that element of the study.
In the study, 257 Type 2 diabetes patients who were subjected to intensive blood-sugar reduction treatment died. Only 203 patients, who received standard blood glucose treatment, died in a control group, the newspaper said.
The information translates to three more fatalities per 1,000 patients in the intensive therapy group.
Two other parts of the study of 10,251 people that reportedly aim to lessen blood pressure and cholesterol will carry on until June 2009, when the study is over.
Copyright 2008 by United Press International
Related stories:
Still puzzling: Best care for the frail and elderly with coronary artery disease
A new study from Duke University Medical Center finds that patients treated solely with medications after suffering from chest pain, heart attack or coronary artery disease are more likely to die during the first year following their initial hospitalization.
Psychosocial issues affect HIV/AIDS treatment outcomes
Psychosocial influences such as stress, depression and trauma have been neglected in biomedical and treatment studies involving people infected with HIV, yet they are now known to have significant health impacts on such individuals and the spread of AIDS, according to a University of North Carolina at Chapel Hill scientist.
World-first discovery could help treat life-threatening tumors
WA researchers investigating how blood vessel growth keeps cancers alive have made a world-first discovery that could boost the chances of successfully treating life-threatening tumours.
Novel mechanism found that may boost impaired function of leukemia protein
A new study led by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia. The protein, called AML1, plays a critical role in the development of the blood system and in the production of platelets and immune cells. The findings are published in the March 1, 2008, issue of
Genes & Development.
Novel compound may lessen heart attack damage
A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute. Results of the study, available online and to be published in the February 19 issue of the journal
Circulation, reflect the first time the drug has been tested in humans.
Jefferson neurosurgeons using new liquid treatment for wide-neck brain aneurysm
Neurological surgeons at Jefferson Hospital for Neuroscience are among the first surgeons in the United States using an FDA-approved liquid system for treating wide-necked brain aneurysms, which could eventually replace current treatments.
Regular marijuana use increases risk of hepatitis C-related liver damage
Patients with chronic hepatitis C (HCV) infection should not use marijuana (cannabis) daily, according to a study published in
Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. Researchers found that HCV patients who used cannabis daily were at significantly higher risk of moderate to severe liver fibrosis, or tissue scarring.
Researcher transplants stem cells to try to save patients' legs
A Northwestern University Feinberg School of Medicine researcher has launched the first U.S. trial in which a purified form of subjects' own adult stem cells was transplanted into their leg muscles with severely blocked arteries to try to grow new small blood vessels and restore circulation in their legs.